NetWitness Appoints Industry Veteran Ken Naumann as New CEO
BEDFORD, Mass.–(BUSINESS WIRE)–NetWitness, an RSA® Group Business and globally trusted provider of cybersecurity technologies and…
BEDFORD, Mass.–(BUSINESS WIRE)–NetWitness, an RSA® Group Business and globally trusted provider of cybersecurity technologies and…
Company recognized for innovation in payroll funding and as a financial services provider of the…
Financial Technology Executive Dov Marmor Joins as Chief Business Officer & Head of JellyFi NEW…
Mature and scalable Provider Edge and Carrier Ethernet solutions for converged, wireless and fixed networks…
Data Center Market Analysis 2Q 2022 Recap Compares Absorption Across Three-Major Regions DALLAS–(BUSINESS WIRE)–#2Q2022DataCenterMarketRecap—datacenterHawk, the…
Through its partnership with the Green Hydrogen Organisation (GH2), Hy Stor Energy will also establish…
SetSchedule CEO and co-founder Roy Dekel is recognized as one of the top Innovators in…
Board Member Alicia Pritchett of Fastly Becomes First Woman to Take on SVTA Vice President…
Customers in the Lone Star State Can Now Easily Add a Co-signer When Financing with…
RALEIGH, N.C. & SAN JOSE, Calif.–(BUSINESS WIRE)–#AI—Silver Tree Consulting & Services today announced a partnership…
Joint integration redacts confidential data from files exfiltrated by high-risk and departing employees MINNEAPOLIS–(BUSINESS WIRE)–#insiderrisk—Code42…
Juniper continues to lead in independent third-party tests with excellent security and performance SUNNYVALE, Calif.–(BUSINESS…
All Devices Successfully Detected Colon Entry in Patients with Active Ulcerative Colitis SAN DIEGO, Aug….
Next-generation topical PDE4 inhibitor for adults and adolescents with plaque psoriasis now available in pharmacies…
BRIDGEWATER, N.J., Aug. 10, 2022 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or…
– Habib Dable, Former President and CEO of Acceleron Pharma, and Susan Alesina, Vice President,…
AMITYVILLE, N.Y., Aug. 10, 2022 (GLOBE NEWSWIRE) — The Greenrose Holding Company Inc. (OTC: GNRS,…
Planned re-submission of ONS-5010 / LYTENAVA™ (bevacizumab-vikg) Biologics License Application (BLA) to U.S. Food and…
Trial to Continue as Planned SAN DIEGO, Aug. 10, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals,…
ATLANTA, Aug. 10, 2022 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global…